NO303447B1 - AnalogifremgangsmÕte for fremstilling av et terapeutisk aktivt hydrokloridsalt eller etandisulfonatsalt av 5-(2-klor-1-hydroksyetyl)-4-metyltiazol - Google Patents
AnalogifremgangsmÕte for fremstilling av et terapeutisk aktivt hydrokloridsalt eller etandisulfonatsalt av 5-(2-klor-1-hydroksyetyl)-4-metyltiazolInfo
- Publication number
- NO303447B1 NO303447B1 NO930452A NO930452A NO303447B1 NO 303447 B1 NO303447 B1 NO 303447B1 NO 930452 A NO930452 A NO 930452A NO 930452 A NO930452 A NO 930452A NO 303447 B1 NO303447 B1 NO 303447B1
- Authority
- NO
- Norway
- Prior art keywords
- salt
- methylthiazole
- hydroxyethyl
- chloro
- preparation
- Prior art date
Links
- OOKATFCTRGAPQX-UHFFFAOYSA-N 2-chloro-1-(4-methyl-1,3-thiazol-5-yl)ethanol Chemical compound CC=1N=CSC=1C(O)CCl OOKATFCTRGAPQX-UHFFFAOYSA-N 0.000 title abstract 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 title 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical class OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 title 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9002659A SE9002659D0 (sv) | 1990-08-15 | 1990-08-15 | New pharmaceutical formulations |
| PCT/SE1991/000522 WO1992003134A1 (en) | 1990-08-15 | 1991-08-07 | New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO930452D0 NO930452D0 (no) | 1993-02-09 |
| NO930452L NO930452L (no) | 1993-02-09 |
| NO303447B1 true NO303447B1 (no) | 1998-07-13 |
Family
ID=20380161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO930452A NO303447B1 (no) | 1990-08-15 | 1993-02-09 | AnalogifremgangsmÕte for fremstilling av et terapeutisk aktivt hydrokloridsalt eller etandisulfonatsalt av 5-(2-klor-1-hydroksyetyl)-4-metyltiazol |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5385921A (cs) |
| EP (1) | EP0619734B1 (cs) |
| JP (1) | JP3094077B2 (cs) |
| AT (1) | ATE164066T1 (cs) |
| AU (1) | AU657490B2 (cs) |
| BG (1) | BG97446A (cs) |
| CA (1) | CA2088775A1 (cs) |
| CZ (1) | CZ279586B6 (cs) |
| DE (1) | DE69129126T2 (cs) |
| DK (1) | DK0619734T3 (cs) |
| ES (1) | ES2114891T3 (cs) |
| FI (1) | FI930608A0 (cs) |
| HU (1) | HUT65821A (cs) |
| IE (1) | IE912818A1 (cs) |
| IL (1) | IL99169A (cs) |
| IS (1) | IS3743A7 (cs) |
| LT (1) | LT3978B (cs) |
| LV (1) | LV10921B (cs) |
| NO (1) | NO303447B1 (cs) |
| NZ (1) | NZ239329A (cs) |
| PT (1) | PT98688B (cs) |
| RO (1) | RO112994B1 (cs) |
| RU (1) | RU2093155C1 (cs) |
| SE (1) | SE9002659D0 (cs) |
| SK (1) | SK8793A3 (cs) |
| WO (1) | WO1992003134A1 (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9901658D0 (sv) * | 1999-05-06 | 1999-05-06 | Astra Ab | New formulation |
| SE9904177D0 (sv) * | 1999-11-18 | 1999-11-18 | Astra Ab | Novel compounds |
| AU2002314744A1 (en) | 2001-04-17 | 2002-10-28 | Sepracor, Inc. | Thiazole and other heterocyclic ligands and use thereof |
| CN103772313B (zh) * | 2014-01-02 | 2015-10-14 | 郑桂富 | 一种4-甲基-5-(2-羟乙基)噻唑的合成方法 |
| CN112262814A (zh) * | 2020-10-26 | 2021-01-26 | 宜宾学院 | 油樟叶渣发酵床养鸡方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2825966A1 (de) * | 1978-06-14 | 1980-01-03 | Basf Ag | Saures galvanisches nickelbad, das sulfobetaine als glanz- und einebnungsmittel enthaelt |
| GB8600783D0 (en) * | 1986-01-14 | 1986-02-19 | Merck Sharp & Dohme | N-methyl-d-aspartate receptor antagonists |
-
1990
- 1990-08-15 SE SE9002659A patent/SE9002659D0/xx unknown
-
1991
- 1991-08-07 EP EP91915138A patent/EP0619734B1/en not_active Expired - Lifetime
- 1991-08-07 HU HU9300388A patent/HUT65821A/hu unknown
- 1991-08-07 SK SK8793A patent/SK8793A3/sk unknown
- 1991-08-07 CA CA002088775A patent/CA2088775A1/en not_active Withdrawn
- 1991-08-07 CZ CS93166A patent/CZ279586B6/cs unknown
- 1991-08-07 WO PCT/SE1991/000522 patent/WO1992003134A1/en active IP Right Grant
- 1991-08-07 RO RO93-00194A patent/RO112994B1/ro unknown
- 1991-08-07 AU AU84092/91A patent/AU657490B2/en not_active Ceased
- 1991-08-07 JP JP03514007A patent/JP3094077B2/ja not_active Expired - Lifetime
- 1991-08-07 ES ES91915138T patent/ES2114891T3/es not_active Expired - Lifetime
- 1991-08-07 FI FI930608A patent/FI930608A0/fi unknown
- 1991-08-07 AT AT91915138T patent/ATE164066T1/de not_active IP Right Cessation
- 1991-08-07 RU RU9193004984A patent/RU2093155C1/ru active
- 1991-08-07 DK DK91915138T patent/DK0619734T3/da active
- 1991-08-07 DE DE69129126T patent/DE69129126T2/de not_active Expired - Lifetime
- 1991-08-09 IE IE281891A patent/IE912818A1/en unknown
- 1991-08-09 NZ NZ239329A patent/NZ239329A/en unknown
- 1991-08-12 IL IL9916991A patent/IL99169A/en active IP Right Grant
- 1991-08-14 IS IS3743A patent/IS3743A7/is unknown
- 1991-08-14 PT PT98688A patent/PT98688B/pt not_active IP Right Cessation
- 1991-08-14 US US07/744,914 patent/US5385921A/en not_active Expired - Lifetime
-
1993
- 1993-02-09 NO NO930452A patent/NO303447B1/no not_active IP Right Cessation
- 1993-02-15 BG BG97446A patent/BG97446A/xx unknown
- 1993-08-10 LV LVP-93-1024A patent/LV10921B/en unknown
- 1993-12-30 LT LTIP1714A patent/LT3978B/lt not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI925342L (fi) | Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi | |
| FI96861C (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi | |
| NO179283C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler | |
| FI963424A7 (fi) | Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistami seksi | |
| NO171853C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-(2-(tiazol-4-yl)-2-alkoksyiminoacetamido)-3-((1-pyrazolio)metyl)-3-cefem-4-karboksylat-forbindelser | |
| NO176319C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive furanderivater | |
| NO178543C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive benzopyranderivater | |
| FI930723A0 (fi) | Menetelmä terapeuttisesti aktiivisten tiatsolidiinijohdannaisten valmistamiseksi | |
| NO178068C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive tiazolidindionderivater | |
| NO175528C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive fenylacetamid-derivater | |
| NO903941D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater. | |
| FI925871L (fi) | Menetelmä terapeuttisesti aktiivisten fenyyliguanidiinijohdannaisten valmistamiseksi | |
| NO178338C (no) | Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse samt mellomprodukt | |
| FI903077A0 (fi) | Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia | |
| NO175976C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater | |
| NO178336C (no) | Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter | |
| NO173607C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive tienotriazolo-diazepin-derivater | |
| NO303447B1 (no) | AnalogifremgangsmÕte for fremstilling av et terapeutisk aktivt hydrokloridsalt eller etandisulfonatsalt av 5-(2-klor-1-hydroksyetyl)-4-metyltiazol | |
| NO178698C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater | |
| FI911747L (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen aromaattisten sulfonamidijohdannaisten valmistamiseksi | |
| NO173606C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno- triazolo-diazepin-derivater | |
| FI922835L (fi) | Menetelmä terapeuttisesti aktiivisten piperidiinijohdannaisten valmistamiseksi | |
| FI925518L (fi) | Menetelmä terapeuttisesti aktiivisten 1-piperidinyylialkanoyyliaryylisulfonamidijohdannaisten valmistamiseksi | |
| FI89595B (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva 2-(tioalkylamino)etyl-1H-imidazolderivat | |
| ZA911452B (en) | New use of 5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene-bis(dimethylcarbanate) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN FEBRUARY 2002 |